Largest health care pharmaceutical companies by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Pfizer leads the 61 health care pharmaceutical companies ranked by total assets, at SAR 780.8B, ahead of Johnson & Johnson (SAR 747.2B) and Sanofi (SAR 527.7B). Figures as of 19 Nov 2026, 20:39 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerSAR 780.8B
- Median
- SAR 13.2B
- Combined market value
- SAR 18.6T
- Countries
- 10
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | SAR 780.8B | SAR 588.1B | SAR 103.17 | 1.98% down | 15% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | SAR 747.2B | SAR 2.41T | SAR 999.23 | 2.31% down | 34% up | ||
| 3 | SanofiSNY · Health Care | SAR 527.7B | SAR 413.8B | SAR 172.32 | 2.50% down | 4% down | ||
| 4 | Merck & CoMRK · Health Care | SAR 513.4B | SAR 1.22T | SAR 495.62 | 4.10% down | 45% up | ||
| 5 | AbbVieABBV · Health Care | SAR 502.5B | SAR 1.88T | SAR 1,061.40 | 1.06% down | 25% up | ||
| 6 | AstraZenecaAZN · Health Care | SAR 427.9B | SAR 1.02T | SAR 655.52 | 2.24% down | 1% up | ||
| 7 | Eli LillyLLY · Health Care | SAR 421.9B | SAR 4.52T | SAR 5,075.01 | 2.15% down | 33% up | ||
| 8 | NovartisNVS · Health Care | SAR 416.2B | SAR 1.07T | SAR 566.25 | 2.74% down | 25% up | ||
| 9 | Takeda PharmaceuticalTAK · Health Care | SAR 364.4B | SAR 257.1B | SAR 80.48 | 0.87% up | 51% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | SAR 337.7B | SAR 446.2B | SAR 218.27 | 2.30% down | 30% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | SAR 325.3B | SAR 675.8B | SAR 390.18 | 0.44% down | 16% down | ||
| 12 | GSKGSK · Health Care | SAR 304.3B | SAR 359.2B | SAR 179.22 | 1.65% down | 5% up | ||
| 13 | Novo NordiskNVO · Health Care | SAR 302.2B | SAR 641.3B | SAR 145.50 | 1.62% down | 17% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | SAR 152.8B | SAR 170.5B | SAR 146.10 | 7.77% down | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | SAR 152.1B | SAR 359.1B | SAR 3,471.53 | 2.12% down | 28% up | ||
| 16 | ViatrisVTRS · Health Care | SAR 139.5B | SAR 85.3B | SAR 74.42 | 2.17% down | 99% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | SAR 96.2B | SAR 492.8B | SAR 1,943.88 | 3.40% down | 27% up | ||
| 18 | GrifolsGRFS · Health Care | SAR 82B | SAR 21B | SAR 30.87 | 2.83% down | 0% up | ||
| 19 | Royalty PharmaRPRX · Health Care | SAR 73.6B | SAR 146.1B | SAR 254.06 | 1.37% down | 79% up | ||
| 20 | ZoetisZTS · Health Care | SAR 58B | SAR 123.6B | SAR 304.13 | 5.25% down | 26% down | ||
| 21 | Elanco Animal HealthELAN · Health Care | SAR 50.1B | SAR 49.5B | SAR 99.10 | 1.05% down | 26% up | ||
| 22 | GenmabGMAB · Health Care | SAR 48.3B | SAR 118.3B | SAR 191.90 | 0.37% up | 70% up | ||
| 23 | Jazz PharmaceuticalsJAZZ · Health Care | SAR 43.7B | SAR 56.4B | SAR 878.28 | 5.50% down | 41% up | ||
| 24 | BeOne MedicinesONC · Health Care | SAR 30.7B | SAR 170.9B | SAR 1,496.52 | 1.15% down | 16% up | ||
| 25 | United TherapeuticsUTHR · Health Care | SAR 29.6B | SAR 89.9B | SAR 2,111.27 | 2.51% down | 22% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | SAR 28.5B | SAR 44.7B | SAR 230.72 | 0.13% up | 17% up | ||
| 27 | Dr. Reddy's LaboratoriesRDY · Health Care | SAR 23.1B | SAR 46.5B | SAR 55.76 | 0.77% down | 8% up | ||
| 28 | Roivant SciencesROIV · Health Care | SAR 21.4B | SAR 106.3B | SAR 146.74 | 1.01% up | 91% up | ||
| 29 | Alnylam PharmaceuticalsALNY · Health Care | SAR 18.6B | SAR 74.6B | SAR 556.69 | 0.66% down | 66% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | SAR 13.8B | SAR 27.8B | SAR 79.93 | 2.61% down | 90% up | ||
| 31 | Ionis PharmaceuticalsIONS · Health Care | SAR 13.2B | SAR 17B | SAR 102.03 | 0.69% down | 63% down | ||
| 32 | PTC TherapeuticsPTCT · Health Care | SAR 10.9B | SAR 18.4B | SAR 219.73 | 2.74% down | 21% down | ||
| 33 | AlkermesALKS · Health Care | SAR 9.3B | SAR 29.2B | SAR 173.78 | 1.11% down | 66% up | ||
| 34 | InsmedINSM · Health Care | SAR 8.5B | SAR 119.1B | SAR 543.03 | 20.84% up | 40% down | ||
| 35 | Legend BiotechLEGN · Health Care | SAR 6.5B | SAR 11.7B | SAR 60.50 | 0.74% down | 41% down | ||
| 36 | Ligand PharmaceuticalsLGND · Health Care | SAR 5.9B | SAR 21.6B | SAR 1,078.90 | 3.71% down | 50% up | ||
| 37 | Ascendis PharmaASND · Health Care | SAR 5.4B | SAR 62.9B | SAR 958.32 | 5.49% down | 29% up | ||
| 38 | CytokineticsCYTK · Health Care | SAR 5.3B | SAR 26.9B | SAR 192.97 | 0.24% up | 19% down | ||
| 39 | Arrowhead PharmaceuticalsARWR · Health Care | SAR 5.2B | SAR 23B | SAR 162.81 | 0.68% up | 13% up | ||
| 40 | Madrigal PharmaceuticalsMDGL · Health Care | SAR 4.7B | SAR 34.5B | SAR 1,483.56 | 0.65% down | 27% down | ||
| 41 | TG TherapeuticsTGTX · Health Care | SAR 4B | SAR 37B | SAR 244.79 | 1.30% down | 117% up | ||
| 42 | Praxis Precision MedicinesPRAX · Health Care | SAR 3.5B | SAR 32.7B | SAR 1,168.77 | 2.10% up | 86% up | ||
| 43 | Cogent BiosciencesCOGT · Health Care | SAR 3.5B | SAR 18.3B | SAR 104.97 | 0.63% up | 20% down | ||
| 44 | BridgeBio PharmaBBIO · Health Care | SAR 3.5B | SAR 57B | SAR 292.62 | 0.00% | 21% up | ||
| 45 | Mirum PharmaceuticalsMIRM · Health Care | SAR 3.2B | SAR 23.5B | SAR 359.48 | 3.62% up | 34% up | ||
| 46 | Corcept TherapeuticsCORT · Health Care | SAR 3.1B | SAR 26.8B | SAR 244.53 | 3.84% down | 10% down | ||
| 47 | Belite BioBLTE · Health Care | SAR 2.9B | SAR 23.2B | SAR 570.64 | 2.62% down | 43% up | ||
| 48 | Spyre TherapeuticsSYRE · Health Care | SAR 2.9B | SAR 35B | SAR 368.22 | 3.25% down | 332% up | ||
| 49 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SAR 2.9B | SAR 27.6B | SAR 350.72 | 1.63% down | 129% up | ||
| 50 | Summit TherapeuticsSMMT · Health Care | SAR 2.8B | SAR 31.6B | SAR 39.54 | 0.38% up | 36% down | ||
| 51 | Axsome TherapeuticsAXSM · Health Care | SAR 2.6B | SAR 26.7B | SAR 508.07 | 1.08% up | 6% down | ||
| 52 | Protagonist TherapeuticsPTGX · Health Care | SAR 2.5B | SAR 30.6B | SAR 468.88 | 1.70% down | 51% up | ||
| 53 | ABIVAXABVX · Health Care | SAR 2.4B | SAR 26.5B | SAR 302.39 | 3.84% down | 32% down | ||
| 54 | Travere TherapeuticsTVTX · Health Care | SAR 2.3B | SAR 17.2B | SAR 179.22 | 4.90% down | 45% up | ||
| 55 | Edgewise TherapeuticsEWTX · Health Care | SAR 2.1B | SAR 16.9B | SAR 153.98 | 0.77% down | 86% up | ||
| 56 | Dianthus TherapeuticsDNTH · Health Care | SAR 2B | SAR 18B | SAR 319.81 | 1.52% up | 108% up | ||
| 57 | Oruka TherapeuticsORKA · Health Care | SAR 1.8B | SAR 24.8B | SAR 366.21 | 1.97% up | 255% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | SAR 1.8B | SAR 30.4B | SAR 437.93 | 1.92% down | 18% up | ||
| 59 | Definium TherapeuticsDFTX · Health Care | SAR 1.7B | SAR 15.2B | SAR 111.14 | 1.75% up | 168% up | ||
| 60 | ErascaERAS · Health Care | SAR 1.5B | SAR 18.8B | SAR 53.45 | 3.56% up | 395% up | ||
| 61 | VeradermicsMANE · Health Care | SAR 572.5M | SAR 19.5B | SAR 462.27 | 1.30% down | 231% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR).
Questions and answers
Which health care pharmaceutical companies rank first by total assets?
Pfizer (SAR 780.8B), Johnson & Johnson (SAR 747.2B) and Sanofi (SAR 527.7B) are the top three of the 61 health care pharmaceutical companies ranked by total assets as of 19 Nov 2026, 20:39 UTC.
How many health care pharmaceutical companies are in this ranking?
61 are ranked by total assets.
What are these health care pharmaceutical companies worth together?
The 61 health care pharmaceutical companies ranked by total assets have a combined market value of SAR 18.6T as of 19 Nov 2026, 20:39 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care pharmaceutical companies by total assets”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.